Medical imaging serves as an indispensable tool in advancing clinical research across various medical disciplines. The integration of imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET), enhances our ability to visualize and understand complex physiological processes, aiding in the diagnosis, treatment, and monitoring of diseases. In clinical research, medical imaging plays a pivotal role in assessing treatment efficacy, tracking disease progression, and providing valuable insights into the underlying mechanisms of various medical conditions. Researchers leverage imaging modalities to quantify biological changes, analyze response patterns, and refine therapeutic interventions.
The application of medical imaging in clinical trials enables non-invasive and quantitative assessments, contributing to more objective and reproducible research outcomes. It facilitates the identification of biomarkers, supports patient stratification, and enhances the overall precision of clinical investigations. Collaboration between radiologists, clinicians, and researchers is essential for the successful integration of medical imaging into clinical research protocols. Ethical considerations, patient safety, and data accuracy are paramount in the utilization of imaging technologies, aligning with regulatory standards and ensuring the reliability of research findings.
As technology advances, medical imaging continues to evolve, offering new possibilities for innovative research methodologies and contributing to the development of personalized and precision medicine. The intersection of medical imaging and clinical research remains a dynamic frontier, fostering continuous advancements in healthcare knowledge and patient care.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico